Your browser doesn't support javascript.
loading
Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation.
Badrising, Sushil K; van der Noort, Vincent; van den Eertwegh, Alfons J M; Hamberg, Paul; van Oort, Inge M; van den Berg, Hendrik P; Los, Maartje; Aarts, Maureen J B; Coenen, Jules L L M; Gelderblom, Hans; de Jong, Igle J; Kerver, Emile D; Vrijaldenhoven, Suzan; van Voorthuizen, Theo; Warmerdam, Fabienne; Haanen, John B; Bergman, Andries M.
Afiliação
  • Badrising SK; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van den Eertwegh AJ; Department of Oncology, VU University Medical Center, Amsterdam, the Netherlands.
  • Hamberg P; Department of Oncology & Prostate Cancer Center, Sint Franciscus Gasthuis, Rotterdam, the Netherlands.
  • van Oort IM; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
  • van den Berg HP; Department of Oncology Tergooi Ziekenhuizen, Blaricum, the Netherlands.
  • Los M; Department of Oncology, Sint Antonius Hospital, Nieuwegein, the Netherlands.
  • Aarts MJ; Department of Medical Oncology, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Coenen JL; Department of Oncology, Isala Klinieken, Zwolle, the Netherlands.
  • Gelderblom H; Department of Clinical Oncology, Leiden University Medical Center, the Netherlands.
  • de Jong IJ; Department of Urology, University of Groningen, Groningen, the Netherlands.
  • Kerver ED; Department of Oncology, OLVG Hospital, Amsterdam, the Netherlands.
  • Vrijaldenhoven S; Department of Internal Medicine, Medisch Centrum Alkmaar, Alkmaar, the Netherlands.
  • van Voorthuizen T; Department of Oncology, Rijnstate Hospital, Arnhem, the Netherlands.
  • Warmerdam F; Department of Internal Medicine/Oncology, Atrium-Orbis Medical Center, Heerlen, the Netherlands.
  • Haanen JB; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Bergman AM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Prostate ; 76(1): 32-40, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26390914
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Taxoides / Neoplasias de Próstata Resistentes à Castração / Androstenos Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Taxoides / Neoplasias de Próstata Resistentes à Castração / Androstenos Idioma: En Ano de publicação: 2016 Tipo de documento: Article